Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Binding parameters and thermodynamics of the interaction of imino sugars with a recombinant human acid alpha-glucosidase (alglucosidase alfa): insight into the complex formation mechanism.

Yoshimizu M, Tajima Y, Matsuzawa F, Aikawa S, Iwamoto K, Kobayashi T, Edmunds T, Fujishima K, Tsuji D, Itoh K, Ikekita M, Kawashima I, Sugawara K, Ohyanagi N, Suzuki T, Togawa T, Ohno K, Sakuraba H.

Clin Chim Acta. 2008 May;391(1-2):68-73. doi: 10.1016/j.cca.2008.02.014. Epub 2008 Feb 17.

PMID:
18328816
2.

Acid alpha-glucosidase deficiency (Pompe disease).

Fukuda T, Roberts A, Plotz PH, Raben N.

Curr Neurol Neurosci Rep. 2007 Jan;7(1):71-7. Review.

PMID:
17217857
3.

Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.

Butters TD, Dwek RA, Platt FM.

Glycobiology. 2005 Oct;15(10):43R-52R. Epub 2005 May 18. Review.

4.

Imino sugars and glycosyl hydrolases: historical context, current aspects, emerging trends.

Stütz AE, Wrodnigg TM.

Adv Carbohydr Chem Biochem. 2011;66:187-298. doi: 10.1016/B978-0-12-385518-3.00004-3. Review.

PMID:
22123190
5.

Design and screening strategies for alpha-glucosidase inhibitors based on enzymological information.

Hakamata W, Kurihara M, Okuda H, Nishio T, Oku T.

Curr Top Med Chem. 2009;9(1):3-12. Review.

PMID:
19199993
6.

Therapeutic targets for inhibitors of glycosylation.

Alonzi DS, Butters TD.

Chimia (Aarau). 2011;65(1-2):35-9. Review.

PMID:
21469442
7.

New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.

Butters TD, Dwek RA, Platt FM.

Adv Exp Med Biol. 2003;535:219-26. Review.

PMID:
14714898
8.

Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy.

Katzin LW, Amato AA.

J Clin Neuromuscul Dis. 2008 Jun;9(4):421-31. doi: 10.1097/CND.0b013e318176dbe4. Review.

PMID:
18525427
9.

alpha-glucosidase (CHO) (Genzyme).

Lachmann RH.

Curr Opin Investig Drugs. 2004 Oct;5(10):1101-10. Review.

PMID:
15535432
10.

Differential sensitivity of mouse strains to an N-alkylated imino sugar: glycosphingolipid metabolism and acrosome formation.

van der Spoel AC, Mott R, Platt FM.

Pharmacogenomics. 2008 Jun;9(6):717-31. doi: 10.2217/14622416.9.6.717. Review.

11.

Therapeutic applications of imino sugars in lysosomal storage disorders.

Butters TD, Dwek RA, Platt FM.

Curr Top Med Chem. 2003;3(5):561-74. Review.

PMID:
12570866
12.

Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions.

Chang J, Block TM, Guo JT.

Antiviral Res. 2013 Sep;99(3):251-60. doi: 10.1016/j.antiviral.2013.06.011. Epub 2013 Jun 29. Review.

PMID:
23816430
13.

Iminosugars as therapeutic agents: recent advances and promising trends.

Nash RJ, Kato A, Yu CY, Fleet GW.

Future Med Chem. 2011 Sep;3(12):1513-21. doi: 10.4155/fmc.11.117. Review.

PMID:
21882944
14.

[Iminosugars: current and future therapeutic applications].

Martin O.

Ann Pharm Fr. 2007 Jan;65(1):5-13. Review. French.

PMID:
17299348
15.

Chemical chaperones--a new concept in drug research.

Kolter T, Wendeler M.

Chembiochem. 2003 Apr 4;4(4):260-4. Review. No abstract available.

PMID:
12672104
16.

Natural and synthetic iminosugars as carbohydrate processing enzyme inhibitors for cancer therapy.

Wrodnigg TM, Steiner AJ, Ueberbacher BJ.

Anticancer Agents Med Chem. 2008 Jan;8(1):77-85. Review.

PMID:
18220507
17.

Imino sugar glucosidase inhibitors as broadly active anti-filovirus agents.

Chang J, Guo JT, Du Y, Block T.

Emerg Microbes Infect. 2013 Nov;2(11):e77. doi: 10.1038/emi.2013.77. Epub 2013 Nov 20. Review.

18.

Combinatorial approaches to iminosugars as glycosidase and glycosyltransferase inhibitors.

Cipolla L, La Ferla B, Gregori M.

Comb Chem High Throughput Screen. 2006 Sep;9(8):571-82. Review.

PMID:
17017877
19.

The dual face of endogenous alpha-aminoketones: pro-oxidizing metabolic weapons.

Bechara EJ, Dutra F, Cardoso VE, Sartori A, Olympio KP, Penatti CA, Adhikari A, Assunção NA.

Comp Biochem Physiol C Toxicol Pharmacol. 2007 Jul-Aug;146(1-2):88-110. Epub 2006 Jul 14. Review.

PMID:
16920403
20.

Cardiomyopathy in Pompe's disease.

Fayssoil A.

Eur J Intern Med. 2008 Jan;19(1):57-9. doi: 10.1016/j.ejim.2007.09.018. Epub 2007 Nov 26. Review.

PMID:
18206603
Items per page

Supplemental Content

Write to the Help Desk